Whole-genome sequencing identifies homozygous BRCA2 deletion guiding treatment in dedifferentiated prostate cancer.
about
Whole-genome sequencing identifies homozygous BRCA2 deletion guiding treatment in dedifferentiated prostate cancer.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Whole-genome sequencing identi ...... ifferentiated prostate cancer.
@ast
Whole-genome sequencing identi ...... ifferentiated prostate cancer.
@en
type
label
Whole-genome sequencing identi ...... ifferentiated prostate cancer.
@ast
Whole-genome sequencing identi ...... ifferentiated prostate cancer.
@en
prefLabel
Whole-genome sequencing identi ...... ifferentiated prostate cancer.
@ast
Whole-genome sequencing identi ...... ifferentiated prostate cancer.
@en
P2093
P2860
P50
P356
P1476
Whole-genome sequencing identi ...... ifferentiated prostate cancer.
@en
P2093
Andrew Protheroe
Anna Schuh
Benjamin P Fairfax
David Kerr
Helene Dreau
Ian Roberts
Kevin Gatter
Lisa Browning
Mark Tuthill
Niko Popitsch
P2860
P304
P356
10.1101/MCS.A001362
P577
2017-05-01T00:00:00Z